The diagnosis and management of factor VIII and IX inhibitors: A guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)

被引：102

作者：

Hay, CRM ^{[1
]}

Baglin, TP ^{[1
]}

Collins, PW ^{[1
]}

Hill, FGH ^{[1
]}

Keeling, DM ^{[1
]}

机构：

[1] Univ Manchester, Manchester Royal Infirm, Dept Haematol, Manchester Haemophilia Comprehens Care Ctr, Manchester M13 9WL, Lancs, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2000年 / 111卷 / 01期

关键词：

diagnosis; management; factor VIII/IX inhibitors;

D O I：

10.1046/j.1365-2141.2000.02327.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：78 / 90

页数：13

共 97 条

[81]

2-1

[82] Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention [J].

Santagostino, E ;

Gringeri, A ;

Mannucci, PM .

BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (01) :22-26

[83]

Schulman S, 1996, THROMB HAEMOSTASIS, V76, P344

[84]

Schulman S, 1996, THROMB HAEMOSTASIS, V75, P432

[85] A PROSPECTIVE-STUDY OF TREATMENT OF ACQUIRED (AUTOIMMUNE) FACTOR-VIII INHIBITORS WITH HIGH-DOSE INTRAVENOUS GAMMA-GLOBULIN [J].

SCHWARTZ, RS ;

GABRIEL, DA ;

ALEDORT, LM ;

GREEN, D ;

KESSLER, CM .

BLOOD, 1995, 86 (02) :797-804

[86]

Shapiro AD, 1998, THROMB HAEMOSTASIS, V80, P773

[87] THE EFFECT OF ACTIVATED PROTHROMBIN-COMPLEX CONCENTRATE (FEIBA) ON JOINT AND MUSCLE BLEEDING IN PATIENTS WITH HEMOPHILIA-A AND ANTIBODIES TO FACTOR-VIII - A DOUBLE-BLIND CLINICAL-TRIAL [J].

SJAMSOEDIN, LJM ;

HEIJNEN, L ;

MAUSERBUNSCHOTEN, EP ;

VANGEIJLSWIJK, JL ;

VANHOUWELINGEN, H ;

VANASTEN, P ;

SIXMA, JJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (13) :717-721

[88]

Smith MP, 1999, THROMB HAEMOSTASIS, V81, P35

[89]

SORIANO RMG, 1987, BRIT J RHEUMATOL, V26, P381

[90]

SOULIERES D, 1996, HAEMOPHILIA, V2, P30

← 1 2 3 4 5 6 7 8 9 10 →